TVTX logo

Travere Therapeutics (TVTX) Net income

annual net income:

-$321.55M-$210.15M(-188.64%)
December 31, 2024

Summary

  • As of today (June 18, 2025), TVTX annual net profit is -$321.55 million, with the most recent change of -$210.15 million (-188.64%) on December 31, 2024.
  • During the last 3 years, TVTX annual net income has fallen by -$141.45 million (-78.55%).
  • TVTX annual net income is now -374.27% below its all-time high of $117.24 million, reached on December 31, 2015.

Performance

TVTX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

quarterly net income:

-$41.23M+$19.04M(+31.59%)
March 31, 2025

Summary

  • As of today (June 18, 2025), TVTX quarterly net profit is -$41.23 million, with the most recent change of +$19.04 million (+31.59%) on March 31, 2025.
  • Over the past year, TVTX quarterly net income has increased by +$94.83 million (+69.70%).
  • TVTX quarterly net income is now -127.35% below its all-time high of $150.74 million, reached on September 30, 2023.

Performance

TVTX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

TTM net income:

-$226.71M+$94.83M(+29.49%)
March 31, 2025

Summary

  • As of today (June 18, 2025), TVTX TTM net profit is -$226.71 million, with the most recent change of +$94.83 million (+29.49%) on March 31, 2025.
  • Over the past year, TVTX TTM net income has dropped by -$65.58 million (-40.70%).
  • TVTX TTM net income is now -293.38% below its all-time high of $117.24 million, reached on December 31, 2015.

Performance

TVTX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TVTX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-188.6%+69.7%-40.7%
3 y3 years-78.5%+45.7%-12.1%
5 y5 years-119.6%-5202.2%-116.7%

TVTX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-188.6%at low-127.3%+69.7%-160.4%+35.5%
5 y5-year-188.6%at low-127.3%+69.7%-190.4%+35.5%
alltimeall time-374.3%at low-127.3%+69.7%-293.4%+35.5%

TVTX Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$41.23M(-31.6%)
-$226.71M(-29.5%)
Dec 2024
-$321.55M(+188.6%)
-$60.26M(+9.9%)
-$321.55M(-8.5%)
Sep 2024
-
-$54.81M(-22.2%)
-$351.45M(+140.9%)
Jun 2024
-
-$70.41M(-48.3%)
-$145.91M(-9.4%)
Mar 2024
-
-$136.06M(+50.9%)
-$161.13M(+44.6%)
Dec 2023
-$111.40M(-60.0%)
-$90.17M(-159.8%)
-$111.40M(+28.0%)
Sep 2023
-
$150.74M(-276.0%)
-$87.05M(-71.7%)
Jun 2023
-
-$85.63M(-0.8%)
-$307.44M(+6.4%)
Mar 2023
-
-$86.33M(+31.2%)
-$288.84M(+3.7%)
Dec 2022
-$278.48M(+54.6%)
-$65.82M(-5.5%)
-$278.48M(+5.4%)
Sep 2022
-
-$69.66M(+3.9%)
-$264.23M(+14.8%)
Jun 2022
-
-$67.03M(-11.8%)
-$230.22M(+13.9%)
Mar 2022
-
-$75.97M(+47.3%)
-$202.19M(+12.3%)
Dec 2021
-$180.09M(+6.3%)
-$51.57M(+44.7%)
-$180.09M(-28.0%)
Sep 2021
-
-$35.64M(-8.6%)
-$250.14M(+5.5%)
Jun 2021
-
-$39.01M(-27.6%)
-$237.05M(+5.8%)
Mar 2021
-
-$53.87M(-55.7%)
-$224.11M(+32.3%)
Dec 2020
-$169.43M(+15.7%)
-$121.62M(+439.4%)
-$169.43M(+117.0%)
Sep 2020
-
-$22.55M(-13.5%)
-$78.07M(-15.2%)
Jun 2020
-
-$26.07M(-3326.2%)
-$92.01M(-12.1%)
Mar 2020
-
$808.00K(-102.7%)
-$104.64M(-28.5%)
Dec 2019
-$146.43M(+42.6%)
-$30.26M(-17.1%)
-$146.43M(+18.4%)
Sep 2019
-
-$36.49M(-5.7%)
-$123.62M(-12.7%)
Jun 2019
-
-$38.70M(-5.6%)
-$141.65M(+13.1%)
Mar 2019
-
-$40.98M(+449.7%)
-$125.28M(+22.0%)
Dec 2018
-$102.68M(+71.9%)
-$7.46M(-86.3%)
-$102.68M(-9.0%)
Sep 2018
-
-$54.52M(+144.1%)
-$112.84M(+48.2%)
Jun 2018
-
-$22.33M(+21.5%)
-$76.12M(+13.6%)
Mar 2018
-
-$18.38M(+4.3%)
-$67.02M(+12.2%)
Dec 2017
-$59.73M
-$17.62M(-1.0%)
-$59.73M(+17.8%)
Sep 2017
-
-$17.79M(+34.5%)
-$50.72M(-27.6%)
DateAnnualQuarterlyTTM
Jun 2017
-
-$13.23M(+19.3%)
-$70.03M(-0.2%)
Mar 2017
-
-$11.09M(+28.9%)
-$70.21M(+46.6%)
Dec 2016
-$47.90M(-140.9%)
-$8.60M(-76.8%)
-$47.90M(+14.7%)
Sep 2016
-
-$37.11M(+176.9%)
-$41.77M(-141.4%)
Jun 2016
-
-$13.40M(-219.5%)
$100.92M(+13.7%)
Mar 2016
-
$11.22M(-554.3%)
$88.80M(-24.3%)
Dec 2015
$117.24M(-205.7%)
-$2.47M(-102.3%)
$117.24M(+29.3%)
Sep 2015
-
$105.58M(-513.6%)
$90.68M(-375.8%)
Jun 2015
-
-$25.53M(-164.4%)
-$32.88M(-838.4%)
Mar 2015
-
$39.66M(-236.6%)
$4.45M(-104.0%)
Dec 2014
-$110.94M(+220.4%)
-$29.03M(+61.4%)
-$110.94M(+15.7%)
Sep 2014
-
-$17.98M(-252.3%)
-$95.85M(+8.0%)
Jun 2014
-
$11.80M(-115.6%)
-$88.76M(-16.0%)
Mar 2014
-
-$75.74M(+443.5%)
-$105.62M(+203.9%)
Dec 2013
-$34.63M(+14.1%)
-$13.94M(+27.9%)
-$34.75M(+66.9%)
Sep 2013
-
-$10.90M(+115.9%)
-$20.82M(+109.8%)
Jun 2013
-
-$5.05M(+3.7%)
-$9.92M(+103.4%)
Mar 2013
-
-$4.87M(>+9900.0%)
-$4.88M(>+9900.0%)
Dec 2012
-$30.34M(>+9900.0%)
-
-
Nov 2012
-
-$3700.00(+5.7%)
-$15.00K(+1.4%)
Aug 2012
-
-$3500.00(0.0%)
-$14.80K(0.0%)
May 2012
-
-$3500.00(-18.6%)
-$14.80K(0.0%)
Feb 2012
-
-$4300.00(+22.9%)
-$14.80K(+1.4%)
Feb 2012
-$14.80K(-35.7%)
-
-
Nov 2011
-
-$3500.00(0.0%)
-$14.60K(-13.1%)
Aug 2011
-
-$3500.00(0.0%)
-$16.80K(-15.6%)
May 2011
-
-$3500.00(-14.6%)
-$19.90K(-13.5%)
Feb 2011
-$23.00K
-$4100.00(-28.1%)
-$23.00K(+21.7%)
Nov 2010
-
-$5700.00(-13.6%)
-$18.90K(+43.2%)
Aug 2010
-
-$6600.00(0.0%)
-$13.20K(+100.0%)
May 2010
-
-$6600.00
-$6600.00

FAQ

  • What is Travere Therapeutics annual net profit?
  • What is the all time high annual net income for Travere Therapeutics?
  • What is Travere Therapeutics annual net income year-on-year change?
  • What is Travere Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Travere Therapeutics?
  • What is Travere Therapeutics quarterly net income year-on-year change?
  • What is Travere Therapeutics TTM net profit?
  • What is the all time high TTM net income for Travere Therapeutics?
  • What is Travere Therapeutics TTM net income year-on-year change?

What is Travere Therapeutics annual net profit?

The current annual net income of TVTX is -$321.55M

What is the all time high annual net income for Travere Therapeutics?

Travere Therapeutics all-time high annual net profit is $117.24M

What is Travere Therapeutics annual net income year-on-year change?

Over the past year, TVTX annual net profit has changed by -$210.15M (-188.64%)

What is Travere Therapeutics quarterly net profit?

The current quarterly net income of TVTX is -$41.23M

What is the all time high quarterly net income for Travere Therapeutics?

Travere Therapeutics all-time high quarterly net profit is $150.74M

What is Travere Therapeutics quarterly net income year-on-year change?

Over the past year, TVTX quarterly net profit has changed by +$94.83M (+69.70%)

What is Travere Therapeutics TTM net profit?

The current TTM net income of TVTX is -$226.71M

What is the all time high TTM net income for Travere Therapeutics?

Travere Therapeutics all-time high TTM net profit is $117.24M

What is Travere Therapeutics TTM net income year-on-year change?

Over the past year, TVTX TTM net profit has changed by -$65.58M (-40.70%)
On this page